Glass House Brands (GLAS) Operating Expenses (2020 - 2026)
Glass House Brands (GLAS) posted quarterly Operating Expenses of $24.4 million for Q1 2026, down 5.89% quarter-over-quarter from $25.9 million in Q4 2025.
Glass House Brands (GLAS) Operating Expenses (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Operating Expenses for 7 consecutive years, with $24.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses changed N/A year-over-year to $24.4 million; the TTM figure through Mar 2026 stood at $94.7 million (up 300.68% YoY), while the FY2025 annual figure was $93.5 million, up 2.0% from the prior year.
- Operating Expenses slipped to $24.4 million in Q1 2026 per GLAS's latest filing, from $25.9 million in the prior quarter.
- Across five years, Operating Expenses topped out at $31.8 million in Q4 2023 and bottomed at $6.5 million in Q1 2024.
- Historically, Operating Expenses has averaged $21.1 million across 5 years, with a median of $21.3 million in 2025.
- Annual changes were most pronounced in 2022 — Operating Expenses soared 80.33% — and 2024, when it plunged 67.13%.
- Glass House Brands' Operating Expenses stood at $25.7 million in 2022, then rose by 23.66% to $31.8 million in 2023, then retreated by 25.73% to $23.6 million in 2024, then grew by 9.56% to $25.9 million in 2025, then fell by 5.89% to $24.4 million in 2026.
- Business Quant data shows GLAS's Operating Expenses at $24.4 million in Q1 2026, $25.9 million in Q4 2025, and $23.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Glass House Brands | 828.45 Mn | 809.90 Mn | 15.77 Mn | 18.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.37 Mn |
| Dec 31, 2025 | 25.89 Mn |
| Sep 30, 2025 | 23.14 Mn |
| Jun 30, 2025 | 21.29 Mn |
| Jun 30, 2024 | 23.63 Mn |
| Mar 31, 2024 | 6.47 Mn |
| Dec 31, 2023 | 31.82 Mn |
| Jun 30, 2023 | 21.15 Mn |
| Mar 31, 2023 | 19.67 Mn |
| Dec 31, 2022 | 25.73 Mn |
| Sep 30, 2022 | 18.63 Mn |
| Jun 30, 2022 | 17.28 Mn |
| Mar 31, 2022 | 15.47 Mn |
| Dec 31, 2021 | 19.31 Mn |
| Sep 30, 2021 | 11.87 Mn |
| Jun 30, 2021 | 9.58 Mn |
| Mar 31, 2021 | 10.40 Mn |
| Dec 31, 2020 | 6,857.70 Bn |
| Sep 30, 2020 | 6.09 Mn |
| Mar 31, 2020 | 5.64 Mn |